NIH-funded research NIH-funded research

A new toolset to study how protein modifications work in human cells

Official title: A genetically encoded toolset to decipher the biology of post-translational modifications in the mammalian proteome

Funded at Boston College · NIH-11380694 · Data updated 2026-11-12

A researcher is developing advanced methods to insert specific chemical changes into proteins inside living human cells to learn how these modifications affect function and disease.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionBoston College
NIH-funded
Lab location1 site (Chestnut Hill, United States)
Project startMay 1, 2020
Project endJuly 31, 2030
Funding year2026
Award (this year)$596,750
NIH project number5R35GM136437-07
Project IDNIH-11380694 on NIH RePORTER

Who could benefit from this research

Could help

Patients with autoimmune diseases or cancers could ultimately benefit from improved insights into disease biology and more precise therapeutic strategies.

Less likely to help

There may be no direct benefit to participants in the initial basic science development phase.

What this research studies

This project aims to create and optimize methods that place precise post-translational modifications on proteins in mammalian cells, using genetic code expansion and noncanonical amino acids. By making site-specific modifications in living cells, researchers can study how these changes influence protein behavior in real biological contexts. The work focuses on overcoming current technical barriers to apply these techniques broadly, including better diversity of modified amino acids and easier use in different cell types. If successful, this approach could reveal meaningful connections between protein chemistry and diseases like autoimmunity and cancer.

Why it matters

Potential benefit: If the methods succeed, patients could benefit from accelerated understanding of disease mechanisms and future targeted therapies.

How similar studies have gone: Preliminary and related methods have shown promise in enabling site-specific protein modifications in cells, but broad, robust mammalian application remains an area of active development.

Where this research is happening

  • Boston College
    Chestnut Hill, United States
    Active

Researchers

  • Principal investigator: Chatterjee, Abhishek — Boston College
  • Study coordinator: Chatterjee, Abhishek

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.